Cover image of the article: Should a booster dose be administered in children after mass immunization for hepatitis B?

Image Credit:Hepat Mon

Should a booster dose be administered in children after mass immunization for hepatitis B?

Authors

Selma Tosun1,*, Serol Deveci2, Yunus Kaplan2, Erhun Kasirga2
1Manisa State Hospital, Department of Infectious Diseases and Clinical Microbiology, selma.tosun@yahoo.com, Turkey
2Celal Bayar University, High School of Health, Turkey
*Corresponding Author: Manisa State Hospital, Department of Infectious Diseases and Clinical Microbiology, selma.tosun@yahoo.com, Turkey. Tel: +90-5325120140, +90-2362317570. Fax: +90-2362321748. Email: selma.tosun@yahoo.com

Hepatitis Monthly:Vol. 11, issue 6; 440-444
Published online:Jun 30, 2011
Article type:Research Article
Received:Oct 06, 2010
Accepted:Feb 02, 2011
How to Cite:Tosun S, Deveci S, Kaplan Y, Kasirga E. Should a booster dose be administered in children after mass immunization for hepatitis B?. Hepat Mon. 2011;11(6):. doi:

Abstract

Background: Hepatitis B virus infection is a global health problem and vaccine-preventable disease, but the duration of the effects of HBV vaccination in infants is unknown.
Objectives: The aim of this trial, which comprised children who had received 3 doses as part of the universal HBV immunization program and no additional doses, was to investigate anti-HBs titers and HBsAg status after 9 years.
Patients and Methods: We performed a descriptive, cross-sectional field research study. The study sample, based on sociodemographics and minimum seroprevalence, was analyzed based on 10.00% ± 1.50 (95% confidence interval) (1150 individuals); trial was realized in a total of 1279 children (623 females and 656 males). Anti-HBs titers were measured by micro-EIA (Dia Sorin-Italy); titers < 10 IU/mL were negative, 10-49 IU/mL were low-positive, and > 50 IU/mL were high-positive. For anti-HBs titers below protective levels, HBsAg was measured by micro-EIA.
Results: In approximately half of the children (48.5% in those living in semiurban areas and 42.3% in urban areas), antibody titers were below protective levels.
Conclusions: Mass HBV vaccination, which was implemented in Turkey in 1998, significantly decreases HBsAg positivity in childhood. Nevertheless, it might be necessary to administer a booster dose after 8-9 years in children, especially those in low socioeconomic areas or in whom irregular/insufficient immunization is suspected.


  • Implication for health policy/practice/research/medical education:
    Preventing from HBV infection in infants could not be performed without screening of immune status. Reading this interesting article is recommended to all infectious diseases specialists and immunologists.
  • Please cite this paper as:
    Tosun S, Deveci S, Kaplan Y, Kasirga E. Should a booster dose be administered in children after mass immunization for hepatitis B? Hepat Mon. 2011;11(6):440-4.

2011 Kowsar M.P.Co. All rights reserved.


Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Mar
2004
Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers

Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers

Z Azarkar

Azarkar Z. Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers. J Inflamm Dis. 2024;7(5):e155004. doi:

13
May
2010
Decline of hepatitis B antibody level in vaccinated 5-7 year-old children

Decline of hepatitis B antibody level in vaccinated 5-7 year-old children

Mitra Safari,
Behrouz Yazdanpanah

Safari M, Yazdanpanah B. Decline of hepatitis B antibody level in vaccinated 5-7 year-old children. Zahedan J Res Med Sci. 2010;12(2):e94310. doi:

15
Feb
2004
Long–term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth

Long–term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth

MJ Saffar,
MohammadSadegh Rezaie

Saffar M, Rezaie M. Long–term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. koomesh. 2004;5(1):e151996. doi:

19
Mar
2012
Seroconversion rates after hepatitis-B vaccination in children

Seroconversion rates after hepatitis-B vaccination in children

Mandana Afsharian,
Mohammad Ghaderi,
Siavash Vaziri,
Zahra Leghaei,
Keighobad Ghadiri,
Alireza Janbaksh
,et al.

Afsharian M, Ghaderi M, Vaziri S, Leghaei Z, Ghadiri K, et al. Seroconversion rates after hepatitis-B vaccination in children. J Kermanshah Univ Med Sci. 2012;15(6):e78901. doi:

30
Jun
2009
Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Hamid Galehdari,
Majid Yavarian,
Bita Geramizadeh,
oranous bashti shiraz

Galehdari H, Yavarian M, Geramizadeh B, bashti shiraz O. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.732

More by these authors

Selma TosunPubMedScholar
Serol DeveciPubMedScholar
Yunus KaplanPubMedScholar
Erhun KasirgaPubMedScholar
Share
Cited by
Metrics